Tumori Journal

Papers
(The TQCC of Tumori Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval56
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort43
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer32
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide31
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis16
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study13
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age11
Oral vinorelbine in young patients with desmoid-type fibromatosis10
Chemo-surgical approach in vulvar leiomyosarcoma: A case report10
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer10
Blooming in the rain9
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients8
Ongoing discussion: Is prophylactic central neck dissection necessary in c T 1a-b,2 N 8
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach8
The impact of bio-psycho-social factors on mental health outcomes in patients with solid tumors8
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-20177
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma7
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing7
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network7
ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma6
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients6
Humanistic nursing combined with Neuman’s nursing in the application for oncology patients6
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes6
Advances in spatial multi-omics in tumors6
Expression of concern6
Synergistic effects of XPO1 inhibitors combined with CD19 CAR-T cells in TP53-mutated DLBCL6
Prognostic value of Aurora B expression in cancer patients: A meta-analysis6
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization5
Survey among childhood cancer survivors about their preferences on functionalities of a to-be-developed Survivorship Passport Mobile App5
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects5
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC5
Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy5
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer5
Nutritional status as a risk factor for adverse events associated with L-Asparaginase in children with acute lymphoblastic leukemia5
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report4
KRAS inhibitors in drug resistance and potential for combination therapy4
15th BGICC Abstract Book 20234
Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report4
Personalized treatment using predictive biomarkers in solid organ malignancies: A review4
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes4
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study4
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology4
Ethics in the evaluation of the quality of scientific research: An AIOM-TJ roundtable4
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update4
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease4
Current practices of follow-up programs for childhood cancer survivors in Italy4
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?4
Quality of life and sexual function after breast conservation surgery and mastectomy without reconstruction in South Indian patients3
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice3
Generative AI and medical oncologists: Be curious, but cautious!3
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis3
I was only sixteen3
Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models3
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study3
Precision animal models of tumors: Advances, challenges and clinical translation3
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?3
AIOM Abstract3
Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer3
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy3
Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis3
The impact of body mass index on the treatment response to neoadjuvant chemotherapy in patients with breast cancer: A systematic review and meta-analysis3
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation3
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience3
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance3
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making3
The digital revolution in pathology: Towards a smarter approach to research and treatment3
0.071483135223389